It is fair to say that, economically, a pharmaceutical company’s bottom line requires it to sell products competitively, but a larger viewer should also be taken. The company is in a critical position, market wise in relation to government regulators and the end consumer. This dynamic environment is sometimes difficult to understand and pharmaceutical consultants can definitely benefit the company as it struggles to remain competitive.

FDA regulations require pharmaceutical companies to be in strict compliance, make use of established practices and all safety criteria as they produce products for final use. Marketing plays a critical role in this arrangement and is far more than just a means to an end. As the advisor to the consumer, a pharmacist or physician has a lot of input and must satisfy the patient, whilst also adhering to budgetary restrictions, insurance company stipulations and positions.

If the patient is to be adequately catered to, it is important that lines of communication between pharmaceutical companies and professionals are open and clear and this is where marketing is so important. It follows that the standard of this marketing and its effectiveness directly contributes to the patient’s ability to live a longer, healthier and more productive life. It’s crucial to remember that these forms of marketing represent a two way street. In addition to the company’s communication with the professional about the benefits and risks associated, the science behind the introduction of the products and ways for dissemination and consumption, the professional also communicates back to the company with feedback, real-time findings and data.

The fact that pharma consulting can provide cutting-edge information about conditions and treatments, spotlighting certain illnesses which may not have received much attention, should not be underestimated. Where treatment gaps may have previously existed, the research and work done by the pharmaceutical companies can also raise awareness and enable treatment for patients who may not have realised the treatment was available. There is no guarantee that such amazing products may even find their way into the hands of the sufferer. Marketing plays a critical role in disseminating the information from one end of the chain to the other, into the hands of the professionals for communication with the patient.

Scientific breakthroughs enable the creation of products which are subsequently sanctioned by the government and this whole process focuses on the need for treatment of chronic illnesses. For example, certain side effects or by-products of a critical element may not have been apparent, or the link between illness and cure revealed, unless and until adequate marketing channels are open between the researchers, producers, professionals and patients.

Generally, pharmaceutical consulting firms are highly skilled at developing communication between vital parties and educating all players. Their experience, knowledge and enthusiasm can really help to turn the wheels of the marketing machine, continuously engaging all key players and producing incredible results in such a competitive environment.

Alan Gillies is the Director of L2L Consulting, an elite pharmaceutical consultancy firm which specialises in Strategy Development and Implementation Excellence for prestigious multi-national organisations.